2025-06-19 パシフィック・ノースウェスト国立研究所(PNNL)
<関連情報>
- https://www.pnnl.gov/publications/roles-post-translational-modifications-virus-infection-and-how-proteomics-can-help
- https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1587106/full
プロテオーム全体にわたるPTMの特性解析により、ウイルス感染に対する宿主細胞の応答が明らかになり、抗ウイルス薬の標的が特定される
Proteome-wide characterization of PTMs reveals host cell responses to viral infection and identifies putative antiviral drug targets
Xiaolu Li,Adam Kabza,Ashley N. Ives,Julianne Thiel,Katrina M. Waters,Wei,Jun Qian,Amy C. Sims,Tong Zhang
Frontiers in Immunology Published:30 May 2025
DOI:https://doi.org/10.3389/fimmu.2025.1587106
Post-translational modifications (PTMs) are biochemical modifications that can significantly alter protein structure, function, stability, localization, and interactions with other molecules, thereby activating or inactivating intracellular processes. A growing body of research has begun to highlight the role of PTMs, including phosphorylation, ubiquitination, acetylation, and redox modifications, during virus-host interactions. Collectively, these PTMs regulate key steps in mounting the host immune response and control critical host pathways required for productive viral replication. This has led to the conception of antiviral therapeutics that focus on controlling host protein PTMs, potentially offering pathogen-agnostic treatment options and revolutionizing our capacity to prevent virus transmission. On the other hand, viruses can hijack the host cellular PTM machinery to modify viral proteins in promoting viral replication and evading immune surveillance. PTM regulation during virus-host interactions is complex and poorly mapped, and the development of effective PTM-targeted antiviral drugs will require a more comprehensive understanding of the cellular pathways essential for virus replication. In this review, we discuss the roles of PTMs in virus infection and how technological advances in mass spectrometry-based proteomics can capture systems-level PTM changes during viral infection. Additionally, we explore how such knowledge is leveraged to identify PTM-targeted candidates for developing antiviral drugs. Looking ahead, studies focusing on the discovery and functional elucidation of PTMs, either on the host or viral proteins, will not only deepen our understanding of molecular pathology but also pave the way for developing better drugs to fight emerging viruses.
